Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul E. Freiman Insider Profile
4 Followers
Paul E. Freiman, Director at NovaBay Pharma, holds 1.78K shares in NovaBay Pharma (Ticker: NBY).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+28.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Paul E. Freiman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul E. Freiman
Paul E. Freiman's Trading History
List of latest transactions for each holding click on a transaction to see Paul E. Freiman's performance on stock
You May Also Like
Paul E. Freiman insider profile FAQ
What is the percentage of profitable transactions made by Paul E. Freiman?
The percentage of profitable transactions made by Paul E. Freiman is 50%.
What is the average return per transaction made by Paul E. Freiman?
The average return per transaction made by Paul E. Freiman is 28.20%.
What stocks does Paul E. Freiman hold?
Paul E. Freiman holds: NBY stocks.
What was Paul E. Freiman’s latest transaction?
Paul E. Freiman latest transaction was an Uninformative Buy of ―.
What was Paul E. Freiman's most profitable transaction?
Paul E. Freiman’s most profitable transaction was an Informative Buy of NBY stock on September 13, 2011. The return on the trade was 73.40%.
What is Paul E. Freiman's role in NovaBay Pharma?
Paul E. Freiman's role in NovaBay Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.